Adv. Gershon Shalom Winter, Adv. Tamar Nesher and Adv. Karin Abramovitz of our Firm represented Advanced Dicing Technologies Ltd. – an Israeli based electronics dicing equipment company in its acquisition by Chinese investment fund Neng Yang. See Article
We are proud to have taken part in one of the main innovative projects in the IT and Banking field in Israel. Adv. Alon Tabak Aviram and Adv. Ilan Sapir of our IT Department represented the Digital Bank in its engagement in the Ministry of Finance’s tender to establish a Services Bureau. In addition, Adv. Alon Tabak Aviram and Adv. Ilan Sapir are representing the Digital Bank in its engagement with its future Core-Systems and IT Supplier.
Our firm, supports and represents the Caesarea Edmond Benjamin De Rothschild Assets Corp. (2001) Ltd., in all areas of its activity, and recently, Adv. Galia Suesskind Spiegel and Adv. Mayan Miller of our Real Estate Department, represented the company in its transaction with Mazor Robotics Ltd., for the lease by Mazor of approximately 5,200 sqm in the “Ofek 12” buildings of the Caesarea Smart Business Park.
Adv. Alon Tabak Aviram and Adv. Ilan Sapir of our IT Department represented Bank Mizrahi Tefahot in a transaction for implementation of a new securities market core system. See Article
Adv. Menachem Tulchinsky, Adv. Amit Hirsch and Adv. Shira Efrati of our firm represented Teva Pharmaceutical Industries Ltd. in a motion for discovery prior to submission of a motion for filing a derivative action filed against Teva, under a claim that retirement grants paid by Teva to its former senior office holders are inconsistent with the Company’s Compensation Policy and the law. The District Court rejected the motion for discovery and accepted Teva’s claims in full, imposing legal and attorneys’ fees on the petitioner.
Our Firm supported the establishment of a one-of-a-kind archeological tourist project in Caesarea, which was officially opened in a ceremony attended by President Reuven Rivlin and Baroness Ariane de Rothschild. The opening was preceded by five years of excavation, conservation and reconstruction at great investment by the Edmond De Rothschild Foundation and performed by the Caesarea Edmond Benjamin De Rothschild Corporation, together with the Israel Antiques Authority and the Israel Nature and Parks Authority.
Adv. David Cohen and Adv. Lior Etgar of our firm represented Biond Biologics Ltd in a $17 million financing round led by Israel Biotech Fund and Harel Insurance & Finance Group, with participation of Celgene Corporation, (NASDAQ: CELG), the Japanese-Israeli fund, SBI JI Innovation Fund and existing investors. Biond Biologics is a drug discovery and development company focused on the field of immunotherapy, combining excellent science and out-of-the-box innovative thinking. See Article
Adv. Uri Nesher, Adv. Hila Faber and Adv. Daniel Shil Szriber of our firm represented Jerusalem Venture Partners (JVP) in a $22.5 million financing round led by JVP in Quali Systems, together with investments from existing investors Dell Ventures, Kreos Capital, Evergreen Ventures, Gemini Israel Ventures, and ORR Partners. Quali Systems is a software company focused on automation and orchestration software to deliver environments-as-a-service for digital transformation initiatives aligned with cloud, DevOps and Security. See Article
Adv. Galia Suesskind-Spiegel and Adv. Mayan Miller of our firm represented Caesarea Assets Corporation in the signing of a huge deal with China’s Fosun Pharmaceutical’s Israel-based subsidiary for a 10-year lease of approximately 11,000 m2 of the entire “Ofek 15” building being built by Caesarea Assets Corporation near the Caesarea train station. See Article